Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Coronary Artery Stenosis: later-stage trial registry

1 of 5 indexed Coronary Artery Stenosis trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Coronary Artery Stenosis: 5 US clinical trials tracked, 1 recruiting.

Coronary Artery Stenosis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Abbott Medical Devices, running 3 of these trials.

Enrollment posture brief

Registry condition coronary-artery-stenosis

OPEN 1 | RECR 20% | LATE 1 | EARLY 0 | RANK #3391 | SPON 3

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Coronary Artery Stenosis (th…20%
Open-enrollment share among volume-matched conditions near Coronary Artery Stenosis

Coronary Artery Stenosis lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Coronary Artery Stenosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Coronary Artery Stenosis is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Coronary Artery Stenosis research.

    Abbott Medical Devices accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Coronary Artery Stenosis trials plan to enrol fewer than 100 people.

    Median target enrolment is 71 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Coronary Artery Stenosis splits between interventional and observational designs.

    3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Coronary Artery Stenosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Xience V® Eecss Device
1 trials
MINI TREK RX 1.20 mm Coronary Dilatation Catheter Device
1 trials
Non ionic contrast media comparator Drug
1 trials
Coronary artery stenting: Absorb BVS Device
1 trials
standard CABG Procedure
1 trials
State-of-the-Art Percutaneous Coronary Intervention Procedure
1 trials

US sites by state

Facility locations filed on Coronary Artery Stenosis trials. A trial with sites in several states counts in each.

California 3 trials
Michigan 2 trials
Ohio 1 trials
Maryland 1 trials
Illinois 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Coronary Artery Stenosis page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Coronary Artery Stenosis condition card totals 5 registered trials; most-linked intervention Xience V® Eecss; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.